Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022

Thursday, April 13, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 12, 2017 /PRNewswire/ --The global influenza vaccines market is anticipated to reach nearly US$

5 Billion by 2022. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization
and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market. Geographically, North America is the largest market for influenza vaccines capturing nearly 50% market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2016. Australasia accounted for least share of the influenza vaccines market in 2016. On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines with around XX% share. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2016. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines. In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. Afluria/Fluvax and FluMist/Fluenz stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market. This is the 3rd edition report on influenza vaccines market by iGATE Research. The report titled "Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 216 Page report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market landscape. The Influenza Vaccines Market have been analyzed from 5 viewpoints: 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2022) 2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2022) 3. Global - Influenza Vaccines Brand Sales and Forecast to 2022 4. Global Influenza Vaccines Market - Major Deals 5. Global Influenza Vaccines Market - Driving Factors and Challenges Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region 1. North America 2. Latin America 3. Europe 4. Asia 5. Australasia Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered) 1. United States 2. Canada 3. Brazil 4. Mexico 5. Germany 6. France 7. Italy 8. Spain 9. United Kingdom 10. Netherlands 11. Ireland 12. Denmark 13. Luxembourg 14. Sweden 15. Australia 16. New Zealand 17. Japan 18. China 19. India 20. South Korea 21. Singapore 22. Hong Kong 23. Malaysia 24. Thailand 25. Indonesia Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed 1. Fluarix/FluLaval 2. Fluzone 3. Fluvirin/Flucelvax 4. Influvac 5. Afluria/Fluvax 6. FluMist/Fluenz 7. Flublok Research Methodologies Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc. Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases Read the full report: http://www.reportlinker.com/p04822050-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-influenza-vaccines-market-persons-vaccinated-brand-analysis-and-forecast-to-2022-300439098.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook